Optogenetic measurement of presynaptic calcium transients using conditional genetically encoded calcium indicator expression in dopaminergic neurons

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Sgobio, Carmelo ^a   Kupferschmidt, David A ^b   Cui, Guohong ^b   Sun, Lixin ^a   Li, Zheng ^c   Cai, Huaibin ^a   Lovinger, David M ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR; SEROTONIN; CALCIUM CHANNEL; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PITX3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ELECTROSTIMULATION; FLUORESCENCE ANALYSIS; GENETIC CODE; MOUSE; NERVE FIBER; NERVE STIMULATION; NONHUMAN; OPTOGENETICS; PRESYNAPTIC CALCIUM TRANSIENT; PRESYNAPTIC NERVE; SIGNAL TRANSDUCTION; ACTION POTENTIAL; ANIMAL; C57BL MOUSE; FLUORESCENCE; METABOLISM; NEOSTRIATUM; PHENOTYPE; PROCEDURES; PSYCHOMOTOR PERFORMANCE; SYNAPTIC TRANSMISSION; SYNAPTOSOME; TRANSGENIC MOUSE;

ACTION POTENTIALS; ANIMALS; AXONS; CALCIUM; CALCIUM CHANNELS; DOPAMINERGIC NEURONS; FLUORESCENCE; HOMEODOMAIN PROTEINS; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOSTRIATUM; OPTOGENETICS; PHENOTYPE; PRESYNAPTIC TERMINALS; PSYCHOMOTOR PERFORMANCE; RECEPTORS, CHOLINERGIC; SEROTONIN; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TRANSCRIPTION FACTORS;

EID: 84910020981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111749     Document Type: Article

References (44)

1. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, et al. (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29: 444-453.
2. Gerfen CR, Surmeier DJ (2011) Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34: 441-466.
3. Calabresi P, Mercuri NB, Sancesario G, Bernardi G (1993) Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain 116 (Pt 2): 433-452.
4. Carlsson A (2002) Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems. J Neural Transm 109: 777-787.
5. Phillips PE, Stamford JA (2000) Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by regular' and burst' firing. Brain Res 884: 139-146.
6. Palmer AE, Tsien RY (2006) Measuring calcium signaling using genetically targetable fluorescent indicators. Nat Protoc 1: 1057-1065.
7. Tian L, Hires SA, Mao T, Huber D, Chiappe ME, et al. (2009) Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat Methods 6: 875-881.
8. Walker AS, Burrone J, Meyer MP (2013) Functional imaging in the zebrafish retinotectal system using RGECO. Front Neural Circuits 7: 34.
9. Nikolaou N, Lowe AS, Walker AS, Abbas F, Hunter PR, et al. (2012) Parametric functional maps of visual inputs to the tectum. Neuron 76: 317-324.
10. Akerboom J, Chen TW, Wardill TJ, Tian L, Marvin JS, et al. (2012) Optimization of a GCaMP calcium indicator for neural activity imaging. J Neurosci 32: 13819-13840.
11. Lin X, Parisiadou L, Gu XL, Wang L, Shim H, et al. (2009) Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 64: 807-827.
12. Lin X, Parisiadou L, Sgobio C, Liu G, Yu J, et al. (2012) Conditional expression of Parkinson's disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J Neurosci 32: 9248-9264.
13. Shigetomi E, Kracun S, Sofroniew MV, Khakh BS (2010) A genetically targeted optical sensor to monitor calcium signals in astrocyte processes. Nat Neurosci 13: 759-766.
14. Jankowsky JL, Slunt HH, Gonzales V, Savonenko AV, Wen JC, et al. (2005) Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med 2: e355.
15. Smits SM, Smidt MP (2006) The role of Pitx3 in survival of midbrain dopaminergic neurons. J Neural Transm Suppl: 57-60.
16. Gong S, Doughty M, Harbaugh CR, Cummins A, Hatten ME, et al. (2007) Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J Neurosci 27: 9817-9823.
17. Chandran JS, Lin X, Zapata A, Hoke A, Shimoji M, et al. (2008) Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiol Dis 29: 505-514.
18. Gibb AJ, Edwards FA (1994) Patch clamp recording from cells in sliced tissues. In: Ogden D, editor. Microelectrode Techniques: The Plymouth Workshop Handbook. Cambridge, UK: The Company of Biologists. 225-274.
19. Yorgason JT, Espana RA, Jones SR (2011) Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202: 158-164.
20. Cai H, Lin X, Xie C, Laird FM, Lai C, et al. (2005) Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J Neurosci 25: 7567-7574.
21. Fallon JH, Moore RY (1978) Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180: 545-580.
22. Ford CP, Gantz SC, Phillips PE, Williams JT (2010) Control of extracellular dopamine at dendrite and axon terminals. J Neurosci 30: 6975-6983.
23. Chen BT, Moran KA, Avshalumov MV, Rice ME (2006) Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release. J Neurochem 96: 645-655.
24. Sung KW, Choi S, Lovinger DM (2001) Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J Neurophysiol 86: 2405-2412.
25. Wu LG, Saggau P (1994) Presynaptic calcium is increased during normal synaptic transmission and paired-pulse facilitation, but not in long-term potentiation in area CA1 of hippocampus. J Neurosci 14: 645-654.
26. Chen TW, Wardill TJ, Sun Y, Pulver SR, Renninger SL, et al. (2013) Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 499: 295-300.
27. Kreitzer AC, Gee KR, Archer EA, Regehr WG (2000) Monitoring presynaptic calcium dynamics in projection fibers by in vivo loading of a novel calcium indicator. Neuron 27: 25-32.
28. De Mei C, Ramos M, Iitaka C, Borrelli E (2009) Getting specialized: presynaptic and postsynaptic dopamine D2 receptors. Curr Opin Pharmacol 9: 53-58.
29. Bello EP, Mateo Y, Gelman DM, Noain D, Shin JH, et al. (2011) Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 14: 1033-1038.
30. Bigornia L, Allen CN, Jan CR, Lyon RA, Titeler M, et al. (1990) D2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells. J Pharmacol Exp Ther 252: 586-592.
31. Wu LG, Saggau P (1997) Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20: 204-212.
32. Dodge FA Jr, Rahamimoff R (1967) Co-operative action a calcium ions in transmitter release at the neuromuscular junction. J Physiol 193: 419-432.
33. Cragg SJ (2006) Meaningful silences: how dopamine listens to the ACh pause. Trends Neurosci 29: 125-131.
34. Rapier C, Lunt GG, Wonnacott S (1988) Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J Neurochem 50: 1123-1130.
35. Zhang L, Doyon WM, Clark JJ, Phillips PE, Dani JA (2009) Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol Pharmacol 76: 396-404.
36. Exley R, Cragg SJ (2008) Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br J Pharmacol 153 Suppl 1: S283-297.
37. Zhou FM, Liang Y, Dani JA (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4: 1224-1229.
38. Rice ME, Patel JC, Cragg SJ (2011) Dopamine release in the basal ganglia. Neuroscience 198: 112-137.
39. Cachope R, Mateo Y, Mathur BN, Irving J, Wang HL, et al. (2012) Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep 2: 33-41.
40. Threlfell S, Clements MA, Khodai T, Pienaar IS, Exley R, et al. (2010) Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 30: 3398-3408.
41. Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, et al. (2012) Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75: 58-64.
42. Fink KB, Gothert M (2007) 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59: 360-417.
43. Sarhan H, Grimaldi B, Hen R, Fillion G (2000) 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice. Naunyn Schmiedebergs Arch Pharmacol 361: 12-18.
44. De Groote L, Olivier B, Westenberg HG (2003) Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice. Eur J Pharmacol 476: 71-77.